4th Quarter - Report
ALERE INC. for ALERE INC.
Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Transportation TRA
H.R. 22, FAST Act- matters related to drug testing Surface transportation authorization legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Health Issues HCR
FDA regulation of in-vitro diagnostic testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Foreign Relations FOR
World Health Organization prequalification program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Medicare/Medicaid MMM
Implementation of the laboratory payment provision of the Protecting Access to Medicare Act of 2014, P.L. 113-93 Medicare reimbursement for rapid point-of-care testing Medicare competitive bidding program for diabetic supplies Medicare coding and fees for drug testing
| Lobbyist | Covered position, as disclosed |
|---|---|
| SETH M RADUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.